Bone and maxillofacial abnormalities in Thalassemia: A review of the literature

Journal of Biological Regulators and Homeostatic Agents

Volumn 22, Issue 4, 2008, Pages 211-216

  Di Matteo, R ^a   Liuzza, F ^a   Manicone, P F ^b   Raffaelli, L ^b   Berardi, D ^c   Perfetti, G ^c   Maccauro, G ^b  

^a Aurelia Hospital   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Bone; Metabolism; Osteoporosis; Thalassemia

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIUM; COLLAGEN TYPE 1; DEFEROXAMINE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROGESTERONE; VITAMIN D;

ANEMIA; BONE DENSITY; BONE MALFORMATION; BONE MATURATION; BONE METABOLISM; BONE NECROSIS; CARDIOMYOPATHY; CLINICAL FEATURE; DISEASE PREDISPOSITION; EDITORIAL; FACE MALFORMATION; FEMUR FRACTURE; FRACTURE FIXATION; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HUMAN; IRON OVERLOAD; JAW DISEASE; MOUTH MALFORMATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; THALASSEMIA; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; BONE DISEASES, METABOLIC; FEMALE; HUMANS; MAXILLOFACIAL ABNORMALITIES; YOUNG ADULT;

EID: 58149327302     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (28)

1. Weatherall DJ. Pathophysiology of thalassemia. Baillieres Clin Haematol 1998; 11:127-46.
2. Cario H, Janka-Schaub G, Janseen G, Jarisch A, Strauss G, Kohne E. Recent developments in iron chelation therapy. Klin Padiatr 2007; 219:158-65.
3. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann NY Acad Sci 2005; 1054:40-7.
4. Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Arch Iran Med 2006; 9:329-34.
5. Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Diabetes mellitus and impaired glucose tolerance in thalassemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. Pediatr Endocrinol Rev 2004; 2(S):285-91.
6. Aydinok Y, Darcan S, Polat A, Kavakli K, Nigli G, Coker M, Kantar M, Cetingul N. Endocrine complications in patients with beta-thalassemia major. J Pediatr 2002; 48:50-4.
7. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltasas D, Tolis G. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 2006; 24:138-45.
8. Vento S, Cainelli F, Cesario F. Infections and thalassemia. Lancet Infect Dis 2006; 6:226-33.
9. Perifanis V, Tziomalos K, Tsatra I, Karyda S, Patsiaoura K, Athanassiou-Metaxa M. Prevalence and severity of liver disease in patients with β-thalassemia major. A single-institution fifteen-year experience. Haematologica 2005; 90:1136-1138.
10. Borgna-Pignatti C, Carnelli V, Caruso V, Dore F, De Mattia D, Di Palma A, Di Gregorio F, Romeo MA, Longhi R, Mangiagli A, Melevendi C, Pizzarelli G, Musumeci S. Tromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99:76-9.
11. Driscoll MC, Hurlet A, Styles L, McKie V, Files B, Olivieri N, Pegelow C, Berman B, Drachtman R, Patel K, Brambilla D. Stroke risk in siblings with sickle cell anemia. Blood 2003; 101:2401-4.
12. Borgogna-Pignatti C, Cappellini MD, De Stefano P, et al. Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major. Blood 2006; 107:3733-7.
13. Origa R, Fiumana E, Gamberini MR, et al. Osteoporosis in beta-thalassemia: Clinical and genetic aspects. Ann NY Acad Sci 2005; 1054:451-6.
14. Cutando Soriano A, Gil Montoya JA, López-González Gárrido J de D. Thalassemias and their dental implications. Med Oral 2002; 7:36-45.
15. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 2003; 88:3966-72.
16. Chan YL, Li CK, Pamg LM, Chik KW. Desferrioxamine-induced long bone changes in thalassaemic patients- radiographic features, prevalence and relations with growth. Clin Radiol 2000; 55:610-4.
17. Chan YL, Pang LM, Chik KW, Cheng JC, Li CK. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol 2002; 32:492-7.
18. Voskaridou E, Stoupa E, Antoniadou L, Premetis E, Konstantopoulos K, Papassotiriou I, Terpos E. Osteoporosis and osteosclerosis in sickle cell/betathalassemia: the role of the RANKL/osteoprotegerin axis. Haematologica 2006; 91:813-6.
19. Perrotta S, Cappellini MD, Bertoldo F, et al. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol 2000; 111:461-6.
20. Pratelli L, Veri E, Fortini M, et al. Chaltion therapy and bone metabolism markers in thalassemia major. J Pediatr Endocrinol Metab 2006; 19:1335-42.
21. Di Matteo R, Liuzza F, Pezzillo F, Gerardino L, Maccauro G. Subtrochanteric femoral fracture in a 26-year-old woman affected by beta-thalassemia major due to minor trauma: analysis of bone modification causing the complication. Clin Ter 2007; 158:425-9.
22. Abu Alhaija ES, Hattab FN, al-Omari MA. Cephalometric measurements and facial deformities in subjects with β-thalassemia major. Eur J Orthod 2002; 24:9-19.
23. Hattab FN, Hazza'a AM, Yassin OM, al-Rimawi HS. Caries risk in patients with thalassaemia major. Int Dent J 2001; 51:35-8.
24. Siamopoulou-Mavridou A, Mavridis A, Galanakis E, Vasakos S, Fatourou H, Lapatsanis P. Flow rate and chemistry of parotid saliva related to dental caries and gingivitis in patients with thalassaemia major. Int J Paediatr Dent 1992; 2:93-7.
25. Lugliè PF, Campus G, Deiola C, Mela MG, Gallisai D. Oral condition, chemistry of saliva, and salivary levels of Streptococcus mutans in thalassemic patients. Clin Oral Investig 2002; 6:223-6.
26. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S-B. Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper. J Am Dent Assoc 2005; 136:1658-68.
27. Gigante A, Torcianti M, Boldrini E, Manzotti S, Falcone G, Greco F, Mattioli-Belmonte M. Vitamin K and D association stimulates in vitro osteoblast differentiation of fracture site derived human mesenchymal stem cells. J Biol Regul Homeost Agents 2008; 22:35-44.
28. Tetè S, Mastrangelo F, Carone L, et al. Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. Int J Immunopathol Pharmacol 2007; 20:819-26.